INBX CIK: 2007919

Inhibrx Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
billions USD
FY23:
−0.19
FY24:
−0.19
FY25:
−0.13
Change from FY23 to FY25
billions USD
FY23:
0.00
FY24:
0.00
FY25:
0.00
Change from FY23 to FY25
billions USD
FY23:
0.20
FY24:
0.07
FY25:
0.10
billions USD
FY23:
0.00
FY24:
−0.13
FY25:
−0.03
(positive)
Change from FY23 to FY25
billions USD
FY23:
−0.20
FY24:
−0.20
FY25:
−0.13

All amounts in billions USD Data source:SEC EDGAR